The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol

Shizuo Narimatsu, Daichi Kazamori, Kazufumi Masuda, Takashi Katsu, Yoshihiko Funae, Shinsaku Naito, Hironori Nakura, Shigeru Yamano, Nobumitsu Hanioka

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The capacity to oxidize bufuralol (BF) and dextromethorphan (DEX) was compared kinetically between human CYP2D6 and four rat CYP2D (CYP2D1, -2D2, -2D3 and -2D4) isoenzymes in a yeast cell expression system. In BF 1″-hydroxylation and DEX O-demethylation, only CYP2D4 showed hook-shaped Eadie-Hofstee plots, the other four CYP2D enzymes exhibiting linear plots. In DEX N-demethylation, rat CYP2D2 did not show any detectable activity under the conditions used, whereas the other four enzymes yielded linear Eadie-Hofstee plots. To elucidate the mechanisms causing the nonlinear kinetics, four CYP2D4 mutants, CYP2D4-F109I, -V123F, -L216F and -A486F, were prepared. CYP2D4-V123F, -L216F and -A486F yielded linear or linear-like Eadie-Hofstee plots for BF 1″-hydroxylation, whereas only CYP2D4-A486F exhibited linear plots for DEX O-demethylation. The substitution of Phe-109 by isoleucine did not have any effect on the oxidative capacity of CYP2D4 for either BF or DEX. These results suggest that the introduction of phenylalanine in the active-site cavity of CYP2D4 simplifies complicated interactions between the substrates and the amino acid residues, but the mechanisms causing the simplification differ between BF and DEX.

Original languageEnglish
Pages (from-to)920-931
Number of pages12
JournalBiochemical Pharmacology
Volume77
Issue number5
DOIs
Publication statusPublished - Mar 1 2009

Fingerprint

Dextromethorphan
Cytochrome P-450 CYP2D6
Rats
Oxidation
Kinetics
Hydroxylation
Isoleucine
Hooks
Enzymes
Phenylalanine
Yeast
Isoenzymes
bufuralol
Catalytic Domain
Substitution reactions
Yeasts
Cells
Amino Acids
Substrates

Keywords

  • Bufuralol
  • CYP2D4
  • CYP2D6
  • Dextromethorphan
  • Nonlinear kinetics
  • Site-directed mutagenesis

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry

Cite this

The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol. / Narimatsu, Shizuo; Kazamori, Daichi; Masuda, Kazufumi; Katsu, Takashi; Funae, Yoshihiko; Naito, Shinsaku; Nakura, Hironori; Yamano, Shigeru; Hanioka, Nobumitsu.

In: Biochemical Pharmacology, Vol. 77, No. 5, 01.03.2009, p. 920-931.

Research output: Contribution to journalArticle

Narimatsu, Shizuo ; Kazamori, Daichi ; Masuda, Kazufumi ; Katsu, Takashi ; Funae, Yoshihiko ; Naito, Shinsaku ; Nakura, Hironori ; Yamano, Shigeru ; Hanioka, Nobumitsu. / The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol. In: Biochemical Pharmacology. 2009 ; Vol. 77, No. 5. pp. 920-931.
@article{406fafe842d34aea876a7ad903c66657,
title = "The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol",
abstract = "The capacity to oxidize bufuralol (BF) and dextromethorphan (DEX) was compared kinetically between human CYP2D6 and four rat CYP2D (CYP2D1, -2D2, -2D3 and -2D4) isoenzymes in a yeast cell expression system. In BF 1″-hydroxylation and DEX O-demethylation, only CYP2D4 showed hook-shaped Eadie-Hofstee plots, the other four CYP2D enzymes exhibiting linear plots. In DEX N-demethylation, rat CYP2D2 did not show any detectable activity under the conditions used, whereas the other four enzymes yielded linear Eadie-Hofstee plots. To elucidate the mechanisms causing the nonlinear kinetics, four CYP2D4 mutants, CYP2D4-F109I, -V123F, -L216F and -A486F, were prepared. CYP2D4-V123F, -L216F and -A486F yielded linear or linear-like Eadie-Hofstee plots for BF 1″-hydroxylation, whereas only CYP2D4-A486F exhibited linear plots for DEX O-demethylation. The substitution of Phe-109 by isoleucine did not have any effect on the oxidative capacity of CYP2D4 for either BF or DEX. These results suggest that the introduction of phenylalanine in the active-site cavity of CYP2D4 simplifies complicated interactions between the substrates and the amino acid residues, but the mechanisms causing the simplification differ between BF and DEX.",
keywords = "Bufuralol, CYP2D4, CYP2D6, Dextromethorphan, Nonlinear kinetics, Site-directed mutagenesis",
author = "Shizuo Narimatsu and Daichi Kazamori and Kazufumi Masuda and Takashi Katsu and Yoshihiko Funae and Shinsaku Naito and Hironori Nakura and Shigeru Yamano and Nobumitsu Hanioka",
year = "2009",
month = "3",
day = "1",
doi = "10.1016/j.bcp.2008.11.006",
language = "English",
volume = "77",
pages = "920--931",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - The mechanism causing the difference in kinetic properties between rat CYP2D4 and human CYP2D6 in the oxidation of dextromethorphan and bufuralol

AU - Narimatsu, Shizuo

AU - Kazamori, Daichi

AU - Masuda, Kazufumi

AU - Katsu, Takashi

AU - Funae, Yoshihiko

AU - Naito, Shinsaku

AU - Nakura, Hironori

AU - Yamano, Shigeru

AU - Hanioka, Nobumitsu

PY - 2009/3/1

Y1 - 2009/3/1

N2 - The capacity to oxidize bufuralol (BF) and dextromethorphan (DEX) was compared kinetically between human CYP2D6 and four rat CYP2D (CYP2D1, -2D2, -2D3 and -2D4) isoenzymes in a yeast cell expression system. In BF 1″-hydroxylation and DEX O-demethylation, only CYP2D4 showed hook-shaped Eadie-Hofstee plots, the other four CYP2D enzymes exhibiting linear plots. In DEX N-demethylation, rat CYP2D2 did not show any detectable activity under the conditions used, whereas the other four enzymes yielded linear Eadie-Hofstee plots. To elucidate the mechanisms causing the nonlinear kinetics, four CYP2D4 mutants, CYP2D4-F109I, -V123F, -L216F and -A486F, were prepared. CYP2D4-V123F, -L216F and -A486F yielded linear or linear-like Eadie-Hofstee plots for BF 1″-hydroxylation, whereas only CYP2D4-A486F exhibited linear plots for DEX O-demethylation. The substitution of Phe-109 by isoleucine did not have any effect on the oxidative capacity of CYP2D4 for either BF or DEX. These results suggest that the introduction of phenylalanine in the active-site cavity of CYP2D4 simplifies complicated interactions between the substrates and the amino acid residues, but the mechanisms causing the simplification differ between BF and DEX.

AB - The capacity to oxidize bufuralol (BF) and dextromethorphan (DEX) was compared kinetically between human CYP2D6 and four rat CYP2D (CYP2D1, -2D2, -2D3 and -2D4) isoenzymes in a yeast cell expression system. In BF 1″-hydroxylation and DEX O-demethylation, only CYP2D4 showed hook-shaped Eadie-Hofstee plots, the other four CYP2D enzymes exhibiting linear plots. In DEX N-demethylation, rat CYP2D2 did not show any detectable activity under the conditions used, whereas the other four enzymes yielded linear Eadie-Hofstee plots. To elucidate the mechanisms causing the nonlinear kinetics, four CYP2D4 mutants, CYP2D4-F109I, -V123F, -L216F and -A486F, were prepared. CYP2D4-V123F, -L216F and -A486F yielded linear or linear-like Eadie-Hofstee plots for BF 1″-hydroxylation, whereas only CYP2D4-A486F exhibited linear plots for DEX O-demethylation. The substitution of Phe-109 by isoleucine did not have any effect on the oxidative capacity of CYP2D4 for either BF or DEX. These results suggest that the introduction of phenylalanine in the active-site cavity of CYP2D4 simplifies complicated interactions between the substrates and the amino acid residues, but the mechanisms causing the simplification differ between BF and DEX.

KW - Bufuralol

KW - CYP2D4

KW - CYP2D6

KW - Dextromethorphan

KW - Nonlinear kinetics

KW - Site-directed mutagenesis

UR - http://www.scopus.com/inward/record.url?scp=59749096859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59749096859&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2008.11.006

DO - 10.1016/j.bcp.2008.11.006

M3 - Article

C2 - 19059219

AN - SCOPUS:59749096859

VL - 77

SP - 920

EP - 931

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 5

ER -